Navigation Links
Cohera Medical and CEO Receive Pittsburgh Tech 50 Awards
Date:9/21/2011

PITTSBURGH, Sept. 21, 2011 /PRNewswire/ -- Cohera Medical, a rapidly growing medical device company, announced today that the Company has received two Pittsburgh Technology Council Tech 50 Awards. Cohera Medical was recognized as the 2011 Life Sciences Company of the Year and its President and Chief Executive Officer, Patrick Daly, was named Pittsburgh CEO of the Year.

"We are honored to be recognized by the Pittsburgh Technology Council as a company that is developing unique and innovative technology that will help surgeons improve the overall care of their patients," said Patrick Daly. "These awards are a reflection of the quality, commitment and passion of our entire team.  We remain fully committed to supporting the technology business in southwest Pennsylvania and making a positive impact on the lives of patients and surgeons worldwide."

The Pittsburgh Technology Council's Tech 50 Awards recognize southwestern Pennsylvania's technology and thought-leading companies, which are innovation pioneers in technology-based industries that have become the backbone of Pittsburgh's new economy. The council has over 270,000 members from more than 1,400 companies across the southwestern Pennsylvania region.

The Life Sciences Company of the Year award is given to a company in the life sciences sector that improves our health and environment.  The Pittsburgh CEO of the Year award is given to a CEO of a Tech 50 category company who makes a substantial contribution to his or her company performance and demonstrates outstanding leadership and high levels of peer esteem.  

"Each year, the Pittsburgh Technology Council's Tech 50 Awards honor those technology companies that demonstrate the strongest growth and advancement in products or sales success, financial strength, corporate citizenship, job growth and retention and innovative product or technology," said Audrey Russo, President and CEO  of the Pittsburgh Tech Council.  "We congratulate Cohera Medical, Patrick Daly and its employees on this accomplishment."

Cohera Medical recently received CE mark approval of its lead product in development, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union and the company plans to begin commercialization in Germany in the third quarter of 2011. Cohera Medical is also actively pursing U.S. FDA approval.

About Cohera Medical

Cohera Medical, Inc.® is a rapidly growing medical device company that is actively developing a line of surgical adhesives. Cohera Medical's products are based on a unique chemical design that is resorbable, non-toxic, easy-to-use, and forms a strong bond between tissue layers. The Company's lead product, TissuGlu® Surgical Adhesive, is designed to reduce fluid accumulation and the need for surgical drains in patients undergoing abdominoplasty (tummy tuck) and other plastic procedures that require the creation of large planar flaps of tissue. Cohera Medical is also developing surgical adhesives for use as bowel sealants, for hernia mesh fixation and for small bone fixation. Outside of the EU, TissuGlu Surgical Adhesive and the other Cohera products are currently indicated for investigational use only and have not yet been approved for medical use by the Food and Drug Administration (FDA) in the U.S. or in any other market

For more information, visit www.coheramed.com.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.


'/>"/>
SOURCE Cohera Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Treated in Clinical Study of Cohera Medicals TissuGlu(R) Surgical Adhesive
2. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
3. Cohera Medical Receives CE Mark Approval for TissuGlu® Surgical Adhesive
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Globus Medical Raises $110 Million in Series E Financing Round
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. Boston University Biomedical Engineers Find Chink in Bacterias Armor
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016 BioNovus Innovations LLC and ... Advancing Medical Innovation (IAMI) today announced a new ... and medical devices. An agreement between ... to license, develop and commercialize medical innovations advanced ... "This partnership represents a significant advance in our ...
(Date:5/3/2016)... , May 3, 2016 ACME ... Whelan and Delaware County Councilman ... Nasal Spray in all ACME pharmacies across ... for Disease Control and Prevention (CDC), naloxone has saved 26,463 lives ... officers in Delaware County were authorized to ...
(Date:5/3/2016)... --  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness Month with ... who tell their personal story and encourage those at risk to get tested and begin ... ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... 2016 , ... Nike Rugby Camp's success is due in large part to ... Elite Rugby Camps and current Nike Camp director, has offered an all abilities rugby ... “I’m excited for our eighth summer here in San Diego,” says Willis. "We take ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of Northeast ... the people of their local community. The agency pledges to select a new ... hope is to bring awareness to important local causes with fundraising and other ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Dr. Elyson ... wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental procedure, ... always problematic, they often are improperly erupted, resulting in risks of complications. By providing ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Francesca Loparco, ... changed her life forever with a same-day LASIK procedure at Christenbury Eye ... eyesight. Dr. Jonathan Christenbury performed her surgery the same day as her in-office consultation ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco Products ... tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . , ... starting at $59.95) uses 2 included CR-123 batteries to produce up to 650 ...
Breaking Medicine News(10 mins):